TREATMENT OF MURINE PULMONARY MUCORMYCOSIS WITH SCH-42427, A BROAD-SPECTRUM TRIAZOLE ANTIFUNGAL DRUG

被引：17

作者：

GOLDANI, LZ

SUGAR, AM

机构：

[1] BOSTON UNIV HOSP,MED CTR,DEPT MED,BOSTON,MA 02218

[2] BOSTON UNIV HOSP,MED CTR,EVANS MEM DEPT CLIN RES,BOSTON,MA 02218

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1994年 / 33卷 / 02期

关键词：

D O I：

10.1093/jac/33.2.369

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：369 / 372

页数：4

共 48 条

[41] HIGHLY STEREOSELECTIVE ACCESS TO NOVEL 2,2,4-TRISUBSTITUTED TETRAHYDROFURANS BY HALOCYCLIZATION - PRACTICAL CHEMOENZYMATIC SYNTHESIS OF SCH-51048, A BROAD-SPECTRUM ORALLY-ACTIVE ANTIFUNGAL AGENT
SAKSENA, AK
GIRIJAVALLABHAN, VM
LOVEY, RG
PIKE, RE
WANG, HY
GANGULY, AK
MORGAN, B
ZAKS, A
PUAR, MS
TETRAHEDRON LETTERS, 1995, 36 (11) : 1787 - 1790
[42] NEBULIZED SHELL CROSSLINKED NANOPARTICLES CARRYING BROAD-SPECTRUM SILVER-BASED ANTIMICROBIALS FOR DEPOT TREATMENT OF CYSTIC FIBROSIS PULMONARY INFECTIONS
Cannon, C. L.
Li, Y.
Hindi, K. M.
Taylor, J. B.
Youngs, W. J.
Wooley, K. L.
PEDIATRIC PULMONOLOGY, 2009, : 308 - 308
[43] ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii
Thomas F. Durand-Réville
Satenig Guler
Janelle Comita-Prevoir
Brendan Chen
Neil Bifulco
Hoan Huynh
Sushmita Lahiri
Adam B. Shapiro
Sarah M. McLeod
Nicole M. Carter
Samir H. Moussa
Camilo Velez-Vega
Nelson B. Olivier
Robert McLaughlin
Ning Gao
Jason Thresher
Tiffany Palmer
Beth Andrews
Robert A. Giacobbe
Joseph V. Newman
David E. Ehmann
Boudewijn de Jonge
John O'Donnell
John P. Mueller
Rubén A. Tommasi
Alita A. Miller
Nature Microbiology, 2
[44] ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii
Durand-Reville, Thomas F.
Guler, Satenig
Comita-Prevoir, Janelle
Chen, Brendan
Bifulco, Neil
Hoan Huynh
Lahiri, Sushmita
Shapiro, Adam B.
McLeod, Sarah M.
Carter, Nicole M.
Moussa, Samir H.
Velez-Vega, Camilo
Olivier, Nelson B.
McLaughlin, Robert
Gao, Ning
Thresher, Jason
Palmer, Tiffany
Andrews, Beth
Giacobbe, Robert A.
Newman, Joseph V.
Ehmann, David E.
de Jonge, Boudewijn
O'Donnell, John
Mueller, John P.
Tommasi, Ruben A.
Miller, Alita A.
NATURE MICROBIOLOGY, 2017, 2 (09):
[45] Crystal Structure of the New Investigational Drug Candidate VT-1598 in Complex with Aspergillus fumigatus Sterol 14α-Demethylase Provides Insights into Its Broad-Spectrum Antifungal Activity
Hargrove, Tatiana Y.
Garvey, Edward P.
Hoekstra, William J.
Yates, Christopher M.
Wawrzak, Zdzislaw
Rachakonda, Girish
Villalta, Fernando
Lepesheva, Galina I.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (07)
[46] Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts
Segal, Brahm H.
Almyroudis, Nikolaos G.
Battiwalla, Minoo
Herbrecht, Raoul
Perfect, John R.
Walsh, Thomas J.
Wingard, John R.
CLINICAL INFECTIOUS DISEASES, 2007, 44 (03) : 402 - 409
[47] Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in healthy volunteers
Schmitt-Hoffmann, A
Roos, B
Heep, M
Schleimer, M
Weidekamm, E
Brown, T
Roehrle, M
Beglinger, C
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) : 279 - 285
[48] BBT-207, a novel, 4th generation, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with broad-spectrum activity to both treatment-emergent and drug-naive mutants for the treatment of NSCLC
Jin, Taiguang Jimmy
Kang, Sang-Uk
Kim, Chulwon
Brenneman, Jehrod
Song, Mihee
Printsev, Pavel
Seo, Bo-Bae
Lee, Yong-Hee
Lee, Sang-Yoon
CANCER RESEARCH, 2022, 82 (12)

← 1 2 3 4 5 →